Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Harrison, , Roy,
DOB: 02-OCT-1969 (Age: 56)
Gender: male
Address:
Flat 4
Dyer route
BA1 Baileyville (United Kingdom)
ID: 7093-553922-4 (ECI)
Report
Date: 22-APR-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 22-APR-2025

Chemistry

Test 22-APR-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 7.0 H 4.6 - 6 %
Glucose [Mass/volume] in Blood 114.5 H 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.6 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.6 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.3 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.5 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 215.3 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 183.1 H 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 134.9 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 43.8 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 8.3 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The results indicate suboptimal glycemic control (elevated HbA1c and fasting glucose), and dyslipidemia (high total cholesterol, LDL, and triglycerides). Renal function, electrolytes, and microalbumin/creatinine ratio are within normal limits. Recommend clinical follow-up for diabetes and lipid management to reduce cardiovascular risk.